Stay updated on Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- ChecktodayChange DetectedAdded a new study site: Tainan, Taiwan. Removed the Tainan City, Taiwan listing and the government funding notice banner to reflect updated site information.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedNo significant changes to core study details are visible; only minor UI/layout adjustments appear across the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange Detected- Updated revision from v3.0.2 to v3.2.0. This indicates a new version release, but does not alter core content or other important data.SummaryDifference0.0%

- Check45 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page is updated to revision v3.0.2 with newer date entries (2025-09-10 and 2025-09-11) and an estimated 'Last Update Posted' notice. Older entries (2023 dates and v3.0.1) were removed, 'Back to Top' was removed, and a new 'Helpful Links Provided by Sanofi EFC15935 Plain Language Results Summary' resource was added.SummaryDifference0.6%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%

Stay in the know with updates to Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant+Palbociclib in ER+/HER2- Advanced Breast Cancer Clinical Trial page.